Ignite Creation Date:
2024-05-05 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000796
Status:
COMPLETED
Last Update Posted:
2021-11-03
First Post:
1999-11-02
Brief Title:
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis MDRTB in HIV-Infected Patients
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Tuberculosis |
| HIV Infections |
Keywords:
| Name | View |
|---|---|
| p-Aminosalicylic Acid | View |
| Isoniazid | View |
| Tuberculosis Pulmonary | View |
| Pyrazinamide | View |
| Pyridoxine | View |
| Ofloxacin | View |
| Rifampin | View |
| AIDS-Related Opportunistic Infections | View |
| Drug Therapy Combination | View |
| Ethambutol | View |
| Clofazimine | View |
| Acquired Immunodeficiency Syndrome | View |
| Amikacin | View |
| Drug Resistance Microbial | View |
| Cycloserine | View |
| Capreomycin Sulfate | View |
| Ethionamide | View |
| Aminosalicylic Acids | View |
| Streptomycin | View |